| Gene symbol | ADGRE2 | Synonyms | CD312, CD97, EMR2, VBU | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.12 | dbXrefs | |
| Description | adhesion G protein-coupled receptor E2 | ||||
| GTO ID | GTC3118 |
| Trial ID | NCT05463640 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | ADGRE2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ADGRE2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | BG-CT-22-002(ADGRE2) |
| Cohort 1 | |||||||||
|
|||||||||